CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 72 enrolled
Drug / intervention
Waitlist control +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03768336
NCT03768336N/AActive
CompareCT.gov

A Stress Management and Resiliency Program for Adolescent and Young Adult Cancer Survivors

Massachusetts General Hospital·interventional·Posted Dec 7, 2018·Updated Apr 14, 2026

In Brief

A clinical study evaluating Waitlist control and 3RP-AYA for Cancer. Active but no longer recruiting, targeting 72 participants across 1 site.

Detailed Summary

This research study aims to explore the feasibility and acceptability of an adapted resiliency group program, called the Relaxation Response Resiliency Program (3RP-AYA), to reduce stress and promote stress-management among adolescents and young adults who have completed treatment for cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/AActive
20192020202120222023202420252026
First PostedDec 7, 2018
Enrollment StartApr 1, 2019
Primary CompletionMar 1, 2023
Study CompletionAug 1, 2026
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 7.6 years ago

Interventions

Waitlist controlother

The 3RP is a group program that-through a variety of mind-body approaches, such as imagery, relaxation, and yoga-seeks to buffer stress and promote psychological resiliency and physical well-being. Waitlist control receives the adapted 3RP program (3RP-AYA) approximately 2 months after study enrollment.

3RP-AYAother

The 3RP is a group program that-through a variety of mind-body approaches, such as imagery, relaxation, and yoga-seeks to buffer stress and promote psychological resiliency and physical well-being.